Suppr超能文献

探索含有联苯核心的 P2Y 受体拮抗剂的替代支架。

Exploration of Alternative Scaffolds for P2Y Receptor Antagonists Containing a Biaryl Core.

机构信息

Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.

Immunity, Inflammation, and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, North Carolina 27709, United States.

出版信息

J Med Chem. 2020 Sep 10;63(17):9563-9589. doi: 10.1021/acs.jmedchem.0c00745. Epub 2020 Aug 6.

Abstract

Various heteroaryl and bicyclo-aliphatic analogues of zwitterionic biaryl P2Y receptor (P2YR) antagonists were synthesized, and affinity was measured in P2YR-expressing Chinese hamster ovary cells by flow cytometry. Given this series' low water solubility, various polyethylene glycol derivatives of the distally binding piperidin-4-yl moiety of moderate affinity were synthesized. Rotation of previously identified 1,2,3-triazole attached to the central -benzoic acid core () provided moderate affinity but not indole and benzimidazole substitution of the aryl-triazole. The corresponding P2YR region is predicted by homology modeling as a deep, sterically limited hydrophobic pocket, with the outward pointing piperidine moiety being the most flexible. Bicyclic-substituted piperidine ring derivatives of naphthalene antagonist , e.g., quinuclidine (MRS4608, IC ≈ 20 nM at hP2YR/mP2YR), or of triazole , preserved affinity. Potent antagonists , , , and (10 mg/kg) protected in an ovalbumin/ mouse asthma model, and PEG conjugate reduced chronic pain. Thus, we expanded P2YR antagonist structure-activity relationship, introducing diverse physical-chemical properties.

摘要

各种杂芳基和双环脂肪族 P2Y 受体(P2YR)两性离子拮抗剂类似物被合成,并通过流式细胞术在表达 P2YR 的中国仓鼠卵巢细胞中测量亲和力。鉴于该系列的低水溶性,合成了具有中等亲和力的远端结合哌啶-4-基部分的各种聚乙二醇衍生物。先前鉴定的连接到中央 -苯甲酸核的 1,2,3-三唑的旋转提供了中等亲和力,但不是吲哚和苯并咪唑取代芳基-三唑。同源建模预测 P2YR 区域为一个深的、空间受限的疏水性口袋,向外指向的哌啶部分最灵活。萘拮抗剂 的双环取代哌啶环衍生物,例如喹诺啶 (MRS4608,在 hP2YR/mP2YR 上的 IC ≈ 20 nM),或三唑 ,保留了亲和力。有效拮抗剂 、 、 、 (10 mg/kg)在卵清蛋白/小鼠哮喘模型中具有保护作用,PEG 缀合物 减轻了慢性疼痛。因此,我们扩展了 P2YR 拮抗剂的结构-活性关系,引入了各种物理化学性质。

相似文献

4
Structure-Guided Modification of Heterocyclic Antagonists of the P2Y Receptor.基于结构的 P2Y 受体杂环拮抗剂的修饰。
J Med Chem. 2018 Jun 14;61(11):4860-4882. doi: 10.1021/acs.jmedchem.8b00168. Epub 2018 May 16.
6
Recent progress on the discovery of P2Y receptor antagonists.新型 P2Y 受体拮抗剂的研究进展。
Eur J Med Chem. 2019 Aug 1;175:34-39. doi: 10.1016/j.ejmech.2019.04.068. Epub 2019 Apr 29.

引用本文的文献

2
Drug-like Antagonists of P2Y Receptor Subtypes: An Update.P2Y 受体亚型的类药拮抗剂:最新进展
J Med Chem. 2025 May 8;68(9):9057-9083. doi: 10.1021/acs.jmedchem.5c00249. Epub 2025 Apr 27.
5
Pharmacological characterization of P2Y receptor subtypes - an update.P2Y 受体亚型的药理学特征——更新。
Purinergic Signal. 2024 Apr;20(2):99-108. doi: 10.1007/s11302-023-09963-w. Epub 2023 Sep 12.
10
Purinergic Signaling in Liver Pathophysiology.嘌呤能信号在肝脏病理生理学中的作用。
Front Endocrinol (Lausanne). 2021 Aug 11;12:718429. doi: 10.3389/fendo.2021.718429. eCollection 2021.

本文引用的文献

1
P2Y Receptor Antagonists Reverse Chronic Neuropathic Pain in a Mouse Model.P2Y受体拮抗剂可逆转小鼠模型中的慢性神经性疼痛。
ACS Med Chem Lett. 2020 Apr 30;11(6):1281-1286. doi: 10.1021/acsmedchemlett.0c00115. eCollection 2020 Jun 11.
3
Targeting acidity in cancer and diabetes.靶向癌症和糖尿病的酸性环境。
Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):273-280. doi: 10.1016/j.bbcan.2019.01.003. Epub 2019 Jan 30.
4
Extracellular nucleotides and nucleosides as signalling molecules.细胞外核苷酸和核苷作为信号分子。
Immunol Lett. 2019 Jan;205:16-24. doi: 10.1016/j.imlet.2018.11.006. Epub 2018 Nov 12.
7
Cubanes in Medicinal Chemistry.药用化学中的笼状化合物
J Med Chem. 2019 Feb 14;62(3):1078-1095. doi: 10.1021/acs.jmedchem.8b00888. Epub 2018 Sep 6.
8
Structure-Guided Modification of Heterocyclic Antagonists of the P2Y Receptor.基于结构的 P2Y 受体杂环拮抗剂的修饰。
J Med Chem. 2018 Jun 14;61(11):4860-4882. doi: 10.1021/acs.jmedchem.8b00168. Epub 2018 May 16.
10
Polypharmacology of conformationally locked methanocarba nucleosides.构象锁定的甲桥核苷的多药理学。
Drug Discov Today. 2017 Dec;22(12):1782-1791. doi: 10.1016/j.drudis.2017.07.013. Epub 2017 Aug 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验